Awards & Accreditations
Patient Stories
(104-25) Real-world evaluation of the HistoSonics Edison® System for treatment of liver tumors across multidisciplinary users
(198-24) A randomized, double-blind, parallel group, placebocontrolled multicenter study to evaluate efficacy, safety and tolerability of ianalumab in participants with diffuse cutaneous systemic sclerosis
By submitting this request, you agree to receive communications from Hoag and accept our Privacy Policy and Terms of Use.